|
ZKSCAN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.190400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.377000E-01 |
| Normal-vs-Stage2 |
6.512000E-01 |
| Normal-vs-Stage3 |
1.202020E-01 |
| Normal-vs-Stage4 |
1.923790E-03 |
| Stage1-vs-Stage2 |
6.085400E-01 |
| Stage1-vs-Stage3 |
1.459170E-01 |
| Stage1-vs-Stage4 |
4.055400E-03 |
| Stage2-vs-Stage3 |
1.479820E-01 |
| Stage2-vs-Stage4 |
2.434400E-02 |
| Stage3-vs-Stage4 |
3.283800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.829200E-01 |
| Normal-vs-AfricanAmerican |
9.447200E-01 |
| Normal-vs-Asian |
1.504580E-01 |
| Caucasian-vs-AfricanAmerican |
9.006400E-01 |
| Caucasian-vs-Asian |
4.355600E-01 |
| AfricanAmerican-vs-Asian |
4.708800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.867400E-01 |
| Normal-vs-Female |
6.150500E-02 |
| Male-vs-Female |
7.697700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.384400E-01 |
| Normal-vs-Extreme_Weight |
7.067800E-02 |
| Normal-vs-Obese |
6.428600E-01 |
| Normal-vs-Extreme_Obese |
7.566800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.200200E-01 |
| Normal_Weight-vs-Obese |
3.063000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.609800E-01 |
| Extreme_Weight-vs-Obese |
5.695900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.486200E-01 |
| Obese-vs-Extreme_Obese |
8.620200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.185400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.934600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.975400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.042300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.739400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.677000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.915800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.436800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.038700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.081220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.223600E-01 |
| Normal-VS-Type2 PRCC |
1.682330E-02 |
| Normal-VS-KIRP CIMP |
4.579600E-01 |
| Normal-VS-Unclassified PRCC |
2.146200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.045300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.730000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.628600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.795800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.878390E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.717800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.124390E-01 |
| Normal-vs-N1 |
2.592400E-01 |
| Normal-vs-N2 |
3.166800E-04 |
| N0-vs-N1 |
9.709400E-01 |
| N0-vs-N2 |
7.607900E-02 |
| N1-vs-N2 |
9.457900E-02 |
|
|
